Huntington’s disease improves ability at some cognitive tests, possibly because neurons become abnormally sensitive to the neurotransmitter glutamate, which is vital for sensory discrimination.

The finding by the Leibniz Research Centre for Working Environment and Human Factors in Germany strengthens the glutamate theory and suggests that the cognitive tasks be used as a test for drugs that block the glutamate response.